We are live on ! Find out more
RBC

Ronald Blue & Co Portfolio holdings

AUM $3.1B
1-Year Est. Return 12.82%
This Fund
S&P 500
This Quarter Est. Return
-8.49%
1 Year Est. Return
+12.82%
3 Year Est. Return
+2.44%
5 Year Est. Return
10 Year Est. Return
AUM
$1.91B
AUM Growth
-$191M
Cap. Flow
-$8.09M
Cap. Flow %
-0.42%
Top 10 Hldgs %
87.17%
Holding
394
New
33
Increased
51
Reduced
202
Closed
90

Sector Composition

Rank Sector Weight
1 Healthcare 1.81%
2 Consumer Staples 1.6%
3 Financials 1.46%
4 Energy 1.16%
5 Technology 1.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIDI icon
1
Vident International Equity Strategy
VIDI
$433M
$556M 29.06%
27,881,646
-3,266,691
-10% -$70M
VBND icon
2
Vident US Bond Strategy ETF
VBND
$523M
$400M 20.9%
8,029,932
-331,264
-4% -$16.4M
VUSE icon
3
Vident US Equity Strategy ETF
VUSE
$675M
$378M 19.77%
15,646,497
+2,422,796
+18% +$62.6M
IAU icon
4
iShares Gold Trust
IAU
$62.9B
$163M 8.54%
7,578,313
-2,205,715
-23% -$47.9M
IEMG icon
5
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
$80.2M 4.19%
2,010,641
+1,839,774
+1,077% +$78.8M
ACWX icon
6
iShares MSCI ACWI ex US ETF
ACWX
$11.5B
$45.7M 2.39%
1,170,945
+349,377
+43% +$14.7M
ACWI icon
7
iShares MSCI ACWI ETF
ACWI
$32.9B
$21.2M 1.11%
392,876
-47,729
-11% -$2.75M
VOO icon
8
Vanguard S&P 500 ETF
VOO
$979B
$8.49M 0.44%
+48,340
New +$8.99M
HCA icon
9
HCA Healthcare
HCA
$87.2B
$7.58M 0.4%
97,952
+388
+0.4% +$34.4K
VGK icon
10
Vanguard FTSE Europe ETF
VGK
$30.7B
$7.08M 0.37%
143,937
-27,549
-16% -$1.46M
XOM icon
11
ExxonMobil
XOM
$644B
$7.01M 0.37%
94,336
-5,406
-5% -$417K
KO icon
12
Coca-Cola
KO
$377B
$6.85M 0.36%
170,831
-1,870
-1% -$74.9K
LLY icon
13
Eli Lilly
LLY
$1.02T
$5.65M 0.3%
67,508
-465
-0.7% -$39.3K
EGN
14
DELISTED
Energen
EGN
$5.54M 0.29%
111,065
+9
+0% +$485
AAPL icon
15
Apple
AAPL
$4.54T
$5.44M 0.28%
197,248
-20,336
-9% -$596K
EEMV icon
16
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.44B
$5.33M 0.28%
106,910
-152,144
-59% -$8.05M
CFR icon
17
Cullen/Frost Bankers
CFR
$10.3B
$5.07M 0.27%
79,789
-260
-0.3% -$17.7K
EFA icon
18
iShares MSCI EAFE ETF
EFA
$78B
$5.05M 0.26%
88,191
-133
-0.2% -$8.21K
AGG icon
19
iShares Core US Aggregate Bond ETF
AGG
$137B
$4.86M 0.25%
44,319
+36,278
+451% +$3.96M
EEM icon
20
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$4.79M 0.25%
146,142
+116,056
+386% +$4.1M
PG icon
21
Procter & Gamble
PG
$336B
$4.37M 0.23%
60,767
-5,363
-8% -$402K
DJP icon
22
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$800M
$3.91M 0.2%
160,061
+139,194
+667% +$3.57M
IVE icon
23
iShares S&P 500 Value ETF
IVE
$49B
$3.49M 0.18%
+41,525
New +$3.71M
MDLZ icon
24
Mondelez International
MDLZ
$79.5B
$2.91M 0.15%
69,444
-2,646
-4% -$114K
DXJ icon
25
WisdomTree Japan Hedged Equity Fund
DXJ
$7.08B
$2.67M 0.14%
+54,798
New +$2.96M

Similar funds

Ronald Blue & Co's Q3 2015 Portfolio in Review

As of Q3 2015, Ronald Blue & Co held 394 positions worth $1.91B, down 9.1% from $2.1B the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Ronald Blue & Co's Q3 2015 filing shows 33 new, 51 increased, 202 reduced and 90 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 48,340 shares worth $8.49M. The largest sale was Vident International Equity Strategy, an estimated $70M.

By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, down from 2.3% a quarter earlier, followed by Consumer Staples and Financials.

  • Ronald Blue & Co's largest Q3 2015 buy was Vanguard S&P 500 ETF: 48,340 shares worth $8.49M.
  • Ronald Blue & Co added most to iShares Core MSCI Emerging Markets ETF in Q3 2015, an estimated $78.8M increase.
  • Ronald Blue & Co's biggest Q3 2015 reduction was Vident International Equity Strategy, cutting an estimated $70M.
  • Ronald Blue & Co fully exited Dover in Q3 2015, selling an estimated $3.75M.
  • Ronald Blue & Co's ten largest holdings make up 87% of its $1.91B portfolio in Q3 2015.
  • Ronald Blue & Co opened 33 new positions and closed 90 in Q3 2015.
  • Ronald Blue & Co's portfolio value fell 9.1% quarter-over-quarter to $1.91B.

Based on Ronald Blue & Co's 13F filing for Q3 2015, filed 13 Nov 2015.